Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Undecylenic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 known ✓ | P00915 | 1/20 | 0.44 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | FABP3 | P05413 | 9/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31575764 | 1.00 | ABCC4 (0.61) | ABCC4MAPTFABP3ALDH1A1LMNA | |
| SCHEMBL9359899 | 1.00 | ABCC4 (0.61) | ABCC4MAPTFABP3ALDH1A1LMNA | |
| SCHEMBL18838843 | 0.98 | ABCC4 (0.58) | ABCC4MAPTFABP3ALDH1A1LMNA | |
| SCHEMBL7929595 | 0.95 | ABCC4 (0.61) | ABCC4MAPTFABP3ALDH1A1LMNA | |
| Undecylenic Acid SCHEMBL14357975 | 0.95 | ABCC4 (0.61) | ABCC4MAPTFABP3ALDH1A1LMNA | |
| Potassium Ion SCHEMBL3921191 | 0.95 | ABCC4 (0.61) | ABCC4MAPTFABP3ALDH1A1LMNA | |
| Undecylenic Acid SCHEMBL18985294 | 0.95 | ABCC4 (0.61) | ABCC4MAPTFABP3ALDH1A1LMNA | |
| Potassium Ion SCHEMBL4749548 | 0.95 | ABCC4 (0.61) | ABCC4MAPTFABP3ALDH1A1LMNA | |
| Undecylenic Acid SCHEMBL1004317 | 0.95 | ABCC4 (0.61) | ABCC4MAPTFABP3ALDH1A1LMNA | |
| Lithium Ion SCHEMBL9356507 | 0.95 | ABCC4 (0.61) | ABCC4MAPTFABP3ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 971 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117511000-B | Anti-adhesion agent and breeding colony house modifier comprising same | 成都科宏达科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-4651897-A1 | PERMEATION ENHANCERS FOR GASTROINTESTINAL SYNTHETIC EPITHELIAL LININGS | Syntis Bio, Inc. (US) | 2025-11-26 | — | — | EP | claimed |
| EP-4527861-A1 | FLOW PATTERN REGULATOR FOR WATER-BASED DRILLING FLUID, AND PREPARATION METHOD THEREFOR | China Oilfield Services Ltd. (CN) | 2025-03-26 | — | — | EP | claimed |
| CN-118703139-A | Negative electrode binder of lithium battery and preparation method thereof | 湖南林特科技有限公司 | 2024-09-27 | — | — | CN | claimed |
| CN-118592447-A | Quaternary ammonium salt disinfectant and preparation method thereof | 成都科宏达科技有限公司 | 2024-09-06 | — | — | CN | claimed |
| US-20240261411-A1 | PERMEATION ENHANCERS FOR GASTROINTESTINAL SYNTHETIC EPITHELIAL LININGS | SYNTIS BIO, INC. | 2024-08-08 | — | — | US | claimed |
| WO-2024155958-A1 | PERMEATION ENHANCERS FOR GASTROINTESTINAL SYNTHETIC EPITHELIAL LININGS | SYNTIS BIO, INC. (US) | 2024-07-25 | — | — | WO | claimed |
| EP-3520785-B1 | USES OF BACTERIOSTATIC AGENT FORMULA IN PREPARING COMPOSITION FOR VAGINAL USE AND COMPOSITION FOR VAGINAL USE | SHENZHEN EULIKAN BIOTECHNOLOGY CO LTD (CN) | 2024-07-17 | — | — | EP | claimed |
| CN-117844098-B | Lightweight high-elastic environment-friendly leisure shoe midsole and preparation process thereof | 比音勒芬服饰股份有限公司 | 2024-04-30 | — | — | CN | claimed |
| WO-2024078410-A1 | ORAL DELIVERY OF THERAPEUTIC AGENTS | GUANGZHOU DAZHOU BIOMEDICINE LTD. (CN) | 2024-04-18 | — | — | WO | claimed |
| EP-0750068-B1 | Treatment of gas effluents from a Kraft process using undecylenic and/or undecynoic acid derivatives | ATOCHEM ELF SA (FR) | 1998-03-11 | — | — | EP | claimed |
| US-5719172-A | CONTROLLING GROWTH OF BACTERIA AND/OR FUNGI | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 1998-02-17 | — | — | US | claimed |
| CN-1161234-A | Deodorizer | ATOCHEM ELF SA (FR) | 1997-10-08 | — | — | CN | claimed |
| CN-1142557-A | Process for treatment of gaseous discharges resulting from kraft process using derivatives of undecylenic and/or undecynoic acid | ATOCHEM ELF SA (FR) | 1997-02-12 | — | — | CN | claimed |
| CN-1135708-A | Synergistic antimicrobial compositions comprising 2-(thiocyanomethylthio) benzothiazole and organic acid | BUCKMAN LABOR INC (US) | 1996-11-13 | — | — | CN | claimed |
| EP-0720428-A1 | SYNERGISTIC ANTIMICROBIAL COMPOSITIONS CONTAINING 2-(THIOCYANOMETHYLTHIO)BENZOTHIAZOLE AND AN ORGANIC ACID | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 1996-07-10 | — | — | EP | claimed |
| EP-0461630-B1 | Production process of microspheres | EISAI CO LTD (JP) | 1995-09-13 | — | — | EP | claimed |
| WO-1995008267-A1 | SYNERGISTIC ANTIMICROBIAL COMPOSITIONS CONTAINING 2-(THIOCYANOMETHYLTHIO)BENZOTHIAZOLE AND AN ORGANIC ACID | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 1995-03-30 | — | — | WO | claimed |
| EP-0461630-A2 | Production process of microspheres | Eisai Co., Ltd. (JP) | 1991-12-18 | — | — | EP | claimed |
| US-4942177-A | SODIUM UNDECYLENATE, A SOLVENT WITH EMOLLIENT PROPERTIES | KASTENDIECK KEITH G (US) | 1990-07-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240261411-A1 | PERMEATION ENHANCERS FOR GASTROINTESTINAL SYNTHETIC EPITHELIAL LININGS | FABP2, SLC10A2, FABP6 | CA1 1690/4885ABCC4 423/4885MAPT 4404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.